Comparative analysis of the immunomodulatory effects of extracellular vesicles from canine placental and adipose-derived mesenchymal stem cells.
Ha JH., Ahn JO., Choi JH., Kim SH., Chung JY.
Animal Study on Immune Modulation, published in Am J Vet Res (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Am J Vet Res (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41702062
- DOI
- 10.2460/ajvr.25.12.0426
Abstract (original English)
Objective To compare the immunomodulatory capacities of canine placenta-derived mesenchymal stem cells (PMSCs; MSCs) and adipose-derived MSCs (ADMSCs) as well as the effects of their extracellular vesicles (EVs) on peripheral blood mononuclear cells (PBMCs). Methods PMSCs and ADMSCs were isolated and characterized. The PBMCs were cocultured with each isolated MSC. PBMC viability was assessed by trypan blue, and CD4 expression and PBMC proliferation were analyzed by flow cytometry. Inflammatory cytokines in the supernatants were measured using an ELISA. In addition, each type of MSC-derived EV was extracted and incubated with PBMCs. Subsequently, the same analyses used in the MSC experiments were performed. Statistical analyses used SPSS 26 with the significance set at P Results In MSC experiments, PMSC group exhibited the highest CD4 expression, and PBMC proliferation was also lowest in PMSC group. PBMC viability was significantly lower in PMSC group. A comparison of the inflammatory cytokine concentrations showed similar IL-2 and IL-10 levels in the groups, whereas TNF-α was significantly lower in PMSC group. In EV experiments, the PMSC EV had a greater ability to inhibit PBMC proliferation than the ADMSC EV, whereas CD4 expression showed no difference. PBMC viability and TNF-α concentration were lowest in PMSC EV group, whereas IL-2 concentration was lowest in ADMSC EV group.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.
Systematic Review on Skin Aging, Immune Modulation, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.
- 2026
J Cosmet Dermatol - Level ASystematic ReviewEurope PMC
Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review
Systematic Review on Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Stromal Vascular Fraction in Bone Healing: A Systematic Review of Clinical Evidence and Potential Implications in Skull Base Reconstruction and Cranioplasty.
Systematic Review with a reported sample of 214 on Chronic Wound, Immune Modulation, published in J Craniofac Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 214
J Craniofac Surg - Level AMeta-analysisEurope PMC
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol